# Cytek Biosciences, Inc.: Form 8-K, filed Feb 27, 2025

- Company: [Cytek Biosciences, Inc.](/companies/ctkb.md) (CIK 1831915)
- Form: 8-K
- Filed: 2025-02-27
- Accepted by EDGAR: Feb 27, 2025, 16:09 ET
- Period: 2025-02-27
- Accession: 0001193125-25-039225
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831915/000119312525039225/d829130d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831915/000119312525039225/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831915/000119312525039225/d829130d8k.htm

Filed Feb 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-039225. Last ingested by Listed: Nov 14, 2026, 12:40 ET. No prices; not investment advice.
